The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.
To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes.We studied the relationship between baseline, updated mean and upd...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4186853?pdf=render |
_version_ | 1819259707248869376 |
---|---|
author | Marcus Lind Jaakko Tuomilehto Matti Uusitupa Olle Nerman Johan Eriksson Pirjo Ilanne-Parikka Sirkka Keinänen-Kiukaanniemi Markku Peltonen Aldina Pivodic Jaana Lindström |
author_facet | Marcus Lind Jaakko Tuomilehto Matti Uusitupa Olle Nerman Johan Eriksson Pirjo Ilanne-Parikka Sirkka Keinänen-Kiukaanniemi Markku Peltonen Aldina Pivodic Jaana Lindström |
author_sort | Marcus Lind |
collection | DOAJ |
description | To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes.We studied the relationship between baseline, updated mean and updated (last) value of HbA1c, FPG, 1 hPG and 2 hPG after an oral 75 g glucose tolerance test (OGTT) and acute CVD events in 504 individuals with impaired glucose tolerance (IGT) at baseline enrolled in the Finnish Diabetes Prevention Study.Follow-up of clinical trial.504 individuals with IGT were followed with yearly evaluations with OGTT, FPG and HbA1c.Relative risk of CVD.Over a median follow-up of 9.0 years 34 (6.7%) participants had a CVD event, which increased to 52 (10.3%) over a median follow-up of 13.0 years when including events that occurred among participants following a diagnosis of diabetes. Updated mean HbA1c, 1 hPG and 2 hPG, HR per 1 unit SD of 1.57 (95% CI 1.16 to 2.11), p = 0.0032, 1.51 (1.03 to 2.23), p = 0.036 and 1.60 (1.10 to 2.34), p = 0.014, respectively, but not FPG (p = 0.11), were related to CVD. In analyses of the last value prior to the CVD event the same three glycaemic measurements were associated with the CVD events, with HRs per 1 unit SD of 1.45 (1.06 to 1.98), p = 0.020, 1.55 (1.04 to 2.29), p = 0.030 and 2.19 (1.51 to 3.18), p<0.0001, respectively but only 2 hPG remained significant in pairwise comparisons. Including the follow-up period after diabetes onset updated 2 hPG (p = 0.003) but not updated mean HbA1c (p = 0.08) was related to CVD.Current 2 hPG level in people with IGT is associated with increased risk of CVD. This supports its use in screening for prediabetes and monitoring glycaemic levels of people with prediabetes. |
first_indexed | 2024-12-23T19:14:17Z |
format | Article |
id | doaj.art-3f8b208bdd004b159bfa90d00c94cedf |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-23T19:14:17Z |
publishDate | 2014-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-3f8b208bdd004b159bfa90d00c94cedf2022-12-21T17:34:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10950610.1371/journal.pone.0109506The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes.Marcus LindJaakko TuomilehtoMatti UusitupaOlle NermanJohan ErikssonPirjo Ilanne-ParikkaSirkka Keinänen-KiukaanniemiMarkku PeltonenAldina PivodicJaana LindströmTo determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes.We studied the relationship between baseline, updated mean and updated (last) value of HbA1c, FPG, 1 hPG and 2 hPG after an oral 75 g glucose tolerance test (OGTT) and acute CVD events in 504 individuals with impaired glucose tolerance (IGT) at baseline enrolled in the Finnish Diabetes Prevention Study.Follow-up of clinical trial.504 individuals with IGT were followed with yearly evaluations with OGTT, FPG and HbA1c.Relative risk of CVD.Over a median follow-up of 9.0 years 34 (6.7%) participants had a CVD event, which increased to 52 (10.3%) over a median follow-up of 13.0 years when including events that occurred among participants following a diagnosis of diabetes. Updated mean HbA1c, 1 hPG and 2 hPG, HR per 1 unit SD of 1.57 (95% CI 1.16 to 2.11), p = 0.0032, 1.51 (1.03 to 2.23), p = 0.036 and 1.60 (1.10 to 2.34), p = 0.014, respectively, but not FPG (p = 0.11), were related to CVD. In analyses of the last value prior to the CVD event the same three glycaemic measurements were associated with the CVD events, with HRs per 1 unit SD of 1.45 (1.06 to 1.98), p = 0.020, 1.55 (1.04 to 2.29), p = 0.030 and 2.19 (1.51 to 3.18), p<0.0001, respectively but only 2 hPG remained significant in pairwise comparisons. Including the follow-up period after diabetes onset updated 2 hPG (p = 0.003) but not updated mean HbA1c (p = 0.08) was related to CVD.Current 2 hPG level in people with IGT is associated with increased risk of CVD. This supports its use in screening for prediabetes and monitoring glycaemic levels of people with prediabetes.http://europepmc.org/articles/PMC4186853?pdf=render |
spellingShingle | Marcus Lind Jaakko Tuomilehto Matti Uusitupa Olle Nerman Johan Eriksson Pirjo Ilanne-Parikka Sirkka Keinänen-Kiukaanniemi Markku Peltonen Aldina Pivodic Jaana Lindström The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. PLoS ONE |
title | The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. |
title_full | The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. |
title_fullStr | The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. |
title_full_unstemmed | The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. |
title_short | The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. |
title_sort | association between hba1c fasting glucose 1 hour glucose and 2 hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes |
url | http://europepmc.org/articles/PMC4186853?pdf=render |
work_keys_str_mv | AT marcuslind theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT jaakkotuomilehto theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT mattiuusitupa theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT ollenerman theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT johaneriksson theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT pirjoilanneparikka theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT sirkkakeinanenkiukaanniemi theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT markkupeltonen theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT aldinapivodic theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT jaanalindstrom theassociationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT marcuslind associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT jaakkotuomilehto associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT mattiuusitupa associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT ollenerman associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT johaneriksson associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT pirjoilanneparikka associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT sirkkakeinanenkiukaanniemi associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT markkupeltonen associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT aldinapivodic associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes AT jaanalindstrom associationbetweenhba1cfastingglucose1hourglucoseand2hourglucoseduringanoralglucosetolerancetestandcardiovasculardiseaseinindividualswithelevatedriskfordiabetes |